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ABSTRACT 
This study aimed to compare second-generation frequency-doubling technology (FDT) perimetry with standard 
automated perimetry (SAP) in mild glaucoma. Forty-seven eyes of 47 participants who had mild visual field defect by SAP 
were included in this study. All participants were examined using SITA 24-2 (SITA-SAP) and matrix 24-2 (Matrix-FDT). The 
correlations of global indices and the number of defects on pattern deviation (PD) plots were determined. Agreement 
between two sets regarding the stage of visual field damage was assessed. Pearson’s correlation, intra-cluster 
comparison, paired t-test, and 95% limit of agreement were calculated using SPSS 24.0. The level of significance was set 
at P < 0.05. Although there was no significant difference between global indices, the agreement between the two 
devices regarding the global indices was weak (the limit of agreement for mean deviation was -6.08 to 6.08 and that for 
pattern standard deviation was -4.42 to 3.42). The agreement between SITA-SAP and Matrix-FDT regarding the 
Glaucoma Hemifield Test (GHT) and the number of defective points in each quadrant and staging of the visual field 
damage was also weak. Because the correlation between SITA-SAP and Matrix-FDT regarding global indices, GHT, 
number of defective points, and stage of the visual field damage in mild glaucoma is weak, Matrix-FDT cannot be used 
interchangeably with SITA-SAP in the early stages of glaucoma. 
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INTRODUCTION
Glaucoma is a chronic life-long optic neuropathy because 
degeneration of ganglion cells and optic nerve 
impairment occurs slowly [1, 2]. People become aware of 
their problem after involvement of the central visual field 
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[3]. Visual field testing by using a technique named 
perimetry helps locate the damaged areas [4]. Many 
patients with glaucoma may have to undergo various 
visual field tests during follow-up. Standard automated 
perimetry (SAP) is widely applied to diagnose and follow-
up glaucoma. The most commonly acquired perimetric 
test is SAP with the Swedish interactive thresholding 
algorithm (SITA) strategy [5]. In the 1990s, frequency-
doubling technology (FDT) perimetry was introduced to 
detect field loss due to glaucoma earlier than SAP [6]. 
The conceptual basis of FDT is the frequency-doubling 
illusion that is due to presentation of a sinusoidal grating 
with a low spatial frequency at a high temporal 
frequency. This type of presentation produces a 
perceived image that appears double its actual spatial 
frequency [7]. One function of the magnocellular 
pathway is the ability to perceive this illusion. However, 
this ability is lost in the early stages of glaucoma [8]. 
Large stimulus size, low spatial resolution, and reduced 
potential to localize the defects have limited the clinical 
profitableness of first-generation FDT [9, 10]. With the 
second version of FDT, Matrix FDT-2, each target 
subtends 5 degrees of visual angle instead of the 15 
degrees in the previous version and the stimuli are 
presented as a pattern as in SAP [11]. Several studies 
have compared FDT with SAP [12, 13]. Some compared 
full-threshold automated perimetry [12], which uses the 
4-2-2 algorithm, but this technique is not commonly used 
in today’s glaucoma practice. Compared to full-threshold 
automated perimetry, the SITA strategy has shorter test 
duration and higher reliability and clinical accuracy [14]. 
Some other studies compared the N-30 version of FDT in 
which each target subtends a large area of about 15 
degrees [13]. In this study, visual field test results 
obtained through Matrix-FDT were compared with those 
obtained through SITA-SAP in mild primary glaucoma. 
The question behind this study was whether smaller 
targets distributed on Matrix-FDT 24-2 in a pattern 
similar to that of the SITA SAP 24-2 test would produce 
any visual field defect comparable with that obtained by 
SITA SAP 24-2 until clinicians would be able to establish a 
relationship between the results of these tests during 
follow-up. 
MATERIALS AND METHODS 
Forty-seven eyes of 47 patients with primary open-angle 
glaucoma (POAG) in the mild stage based on Hodapp–
Parrish–Anderson classification [15] were included in this 
cross-sectional study. The study protocol was approved 
by the Ethics Committee of the Ophthalmic Research 
Center of Shahid Beheshti University of Medical Sciences 
and written consent was obtained from each patient. All 
measurements were obtained in one single day, and all 
participants were enrolled within a 6-month period from 
November 2013 until April 2014 in Labbafinejad Medical 
Center, Shahid Beheshti Medical University, Tehran, Iran. 
All participants had undergone at least one SAP before 
the study so they were familiar with the procedure. None 
of the participants had experience with Matrix-FDT 
testing before the study. A brief display was made for the 
participants to get them familiarized with the procedure. 
The participants who met the inclusion criteria and who 
agreed to participate in the study were enrolled. 
To have a power of 90% to detect a 1-unit difference in 
mean deviation (MD) between two sets when the 
standard deviation of the difference was assumed to be 
2.1, a sample size of 47 was calculated. 
The inclusion criteria were as follows: best-corrected 
visual acuity (BCVA) of logMAR 0.3 or better, spherical 
refraction within 3 diopters (D), and cylinder correction 
within 3 D. A glaucoma specialist examined all 
participants, including VA assessment, slit-lamp 
biomicroscopy, intraocular pressure (IOP) measurement 
with Goldmann applanation tonometry, gonioscopy with 
the Zeiss four-mirror glass, and dilated fundus 
examination 1 day before the tests. Reliable visual fields 
(fixation losses, false-positives, and false-negatives all 
less than 15%) were included. Hodapp–Parrish–Anderson 
criteria [15] were used to determine the severity of visual 
field loss on SAP. Participants with mild visual field 
defects on SAP were included (MD <-6 dB, fewer than 
25% of pattern deviation (PD) points under the 5% level 
and less than seven points under the 1% level, no points 
with sensitivity <15 in the central 5°). Participants with 
other intraocular abnormalities, a disease that might 
affect visual function testing (e.g., pituitary lesions, 
ischemic optic neuropathy, diabetic retinopathy), and 
low test reliability on previous visual fields were excluded 
from the study. 
The visual field of all participants was assessed by Matrix-
FDT (Humphrey Matrix, Carl Zeiss Meditec, and Jena, 
Germany) and the Humphrey Field Analyzer II (Carl Zeiss 
Meditec) in random order. To remove the effect of 
fatigue during the tests, a 10-minute break was allowed 
between each test. The selection of each eye was 
performed randomly. Stimuli of SITA-SAP were 
Goldmann size III (0.43°) on a 31.5-apostilb background, 
which consists of 52 test locations. Stimuli of FDT 
perimetry were 0.25 cyc/deg grating with phase flickers 
at 25 H. FDT perimetry was performed using the 24-2 
full-threshold program with 5° stimuli at 55 test 
locations. The matrix- FDT (24-2) uses an algorithm for 
estimation of threshold. The blind spot and central visual 
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field point are two locations that are tested by FDT 
perimetry, but not by SAP. 
The global indices of visual field and Glaucoma Hemifield 
Test (GHT) measured by matrix-FDT and SAP test were 
compared. The magnitude of the visual field defect 
between FDT and SAP and the number of defects at P < 
0.5, P < 0.2, P < 0.1, and P < 0.05 in each quadrant was 
summed up and compared. FDT visual fields were 
assessed based on the Brusini classification [16]. Stage of 
VF defect detected by FDT was compared with that of 
SAP. Sensitivity threshold in every point of the visual field 
in the FDT was compared with the corresponding point in 
SAP. 
The agreement between SITA-SAP and Matrix-FDT was 
evaluated in patients with POAG with early visual field 
defect by statistical analysis. To present data, mean and 
standard deviation were used. To correlate the 
agreement of two devices regarding global indices, 
hemifields, quadrants, sectors, and single field points, we 
used Pearson’s correlation, intracluster correlation (ICC), 
paired t-test, 95% confidence interval of difference, and 
limit of agreement (LoA). SPSS (Version 21.0, IBM Co., 
Chicago, IL) was used for all statistical analysis. A P-value 
less than 0.05 was regarded as statistically significant. 
RESULTS 
Forty-seven eyes of 47 POAG participants with mild visual 
field damage confirmed by SAP were included in this 
study. There were 19 males and 28 females. The mean 
age of the participants was 53.1 ± 16.2 years. The 
spherical equivalent of refractive error was -0.21 ± 1.88 
and BCVA (log MAR) was 0.14 ± 0.08. Although there was 
no significant difference between global indices, the 
agreement between the two devices regarding global 
indices was weak (Table 1 and Fig 1). 
The LoA for MD was -6.08 to 6.08 and that for pattern 
standard deviation (PSD) was -4.42 to 3.42. The Bland–
Altman plot shows that there was no agreement 
between SITA-SAP and Matrix-FDT regarding MD and 
PSD. In addition, this discrepancy had a trend with 
increasing MD and PSD values (Fig 1A and 1B). The 
agreement between SITA-SAP and Matrix-FDT regarding 
GHT is shown in Table 2 and Fig 2. 
Only 48.8% of the participants had the same results of 
GHT on the two sets (kappa = 0.121). The number of 
defective points at P < 5%, P < 2%, P < 1%, and P < 0.5% 
in supratemporal (ST), supranasal (SN), infratemporal 
(IT), and infranasal (IN) quadrants is shown in Fig 3. 
The correlation between the two devices in terms of 
visual field defects was clinically weak (partial correlation 
= 0.322, P < 0.001) in most of the points (only in 7 points 
out of 54 an r > 0.4 and P < 0.05 was observed). Point-
wise comparison of corresponding locations obtained by 
two sets was weak in most of the points, indicating the 
non-agreement of the measurement of sensitivity of the 
points by the two sets (Fig 4). 
Among the 47 study participants with confirmed early VF 
defect on SITA-SAP, Matrix-FDT visual field defects were 
classified as normal in 13 (27%), early damage in 22 
(46%), moderate damage in 9 (19%), and severe damage 
in 3 (6%). 
 
 
 
 
Table 1: Global Indices and Test Duration of SITA-SAP and Matrix-FDT 
 Mean ± SD Median Minimum Maximum P* 
MD      
SITA-SAP -3.31 ± 2.1 -3.01 -11.52 0.11 0.905 
Matrix-FDT -3.37 ± 3.25 -3.31 -11.96 3.18  
PSD      
SITA-SAP 3 ± 2.13 2.12 1.08 10.92 0.169 
Matrix-FDT 3.51 ± 1.12 3.12 2.33 7.34  
Test duration (s)      
SITA-SAP 347.3 ± 53.7 341 259 482 0.001 
Matrix-FDT 319.9 ± 21.3 314 294 387  
MD: mean deviation, PSD: pattern standard deviation, S: seconds, Matrix-FDT: matrix frequency doubling perimetry, SITA: Swedish interactive 
thresholding algorithm, SAP: standard automated perimetry 
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Figure 1: A: Bland–Altman Plot of Pattern Standard Deviation (PSD) in Matrix Frequency-Doubling Perimetry (FDT) versus Swedish Interactive 
Thresholding Algorithm (SITA) Standard Automated Perimetry (SAP). 
 
B: Bland–Altman Plot of Mean Deviation (MD) in Matrix-FDT versus SITA-SAP. 
 
Table 2: Agreement of MD and PSD between Matrix Frequency-Doubling Perimetry (FDT) and Swedish Interactive Thresholding Algorithm (SITA) 
Standard Automated Perimetry (SAP) 
Parameter of 
interest 
Correlation 
of two sets 
∆ Mean ± 
SD 
∆ Range Absolute ∆ 
Mean ± SD 
P-
value* 
95% CI ICC LoA (lower to 
upper) 
MD 0.259 0.1 ± 3.4 -8.1 to 9.9 2.5 ± 2.2 0.905 -0.94 to 1.06 0.06 -6.56 to 6.76 
PSD 0.071 -0.5 ± 2.5 -5 to 8.3 1.9 ± 1.6 0.169 -1.24 to 0.22 0.24 -5.4 to 4.4 
∆: Difference between SITA-SAP and Matrix-FDT, LoA: limit of agreement, MD: mean deviation, PSD: pattern standard deviation, sd: standard 
deviation, CI: confidence interval, * Based on the paired t-test 
 
 
Figure 2: Agreement between the Matrix Frequency-Doubling Perimetry (FDT) versus Swedish Interactive Thresholding Algorithm (SITA) Standard 
Automated Perimetry (SAP) Regarding the Glaucoma Hemifield Test (GHT). 
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Figure 3: The Number of Defective Points with P < 5%, P < 2%, P < 1%, 
and P < 0.5% at the Superionasal (SN), Superiotemporal (ST), 
Inferionasal (IN), and Inferiotemporal (IT) Quadrants by the Matrix 
Frequency-Doubling Perimetry (FDT) versus Swedish Interactive 
Thresholding Algorithm (SITA) Standard Automated Perimetry (SAP). 
 
 
Figure 4: Pointwise Correlation of Matrix Frequency-Doubling 
Perimetry (FDT) versus Swedish Interactive Thresholding Algorithm 
(SITA) Standard Automated Perimetry (SAP) in Measurement of Mean 
Deviation (MD) within Different Locations of the Visual Field. 
 
DISCUSSION 
In this study, despite no significant difference between 
the global indices of the visual fields, the correlations 
between the two sets were weak in global indices (MD 
and PSD), GHT, number of defective points, point-wise 
comparison of corresponding points, and staging of the 
VF damage. Matrix-FDT has high sensitivity and 
specificity compared to SITA-SAP to detect visual field 
deficits [11]. Because Matrix-FDT (30-2 screening 
protocol) evaluates 19 locations while SITA-SAP (30-2 
protocol) evaluates 76, direct comparison of Matrix-FDT 
findings with SITA-SAP findings was difficult. By 
introduction of a newer generation of FDT, which uses a 
smaller target similar to that of SITA-SAP, Matrix-FDT 
could be used with the benefit of detecting mild 
glaucomatous VF abnormalities. However, a correlation 
between Matrix-FDT and SITA-SAP was not detected in 
our study. Matrix-FDT and SITA-SAP measure different 
entities of retinal sensitivity. Frequency-doubling 
technology uses contrast sensitivity threshold to counter 
phase flickering of sinusoidal waves [7], while SITA-SAP 
uses white light intensity. Therefore, the threshold values 
obtained by each device were not expected to be directly 
comparable, as was shown by point-wise comparison of 
the thresholds in the fields. The two tests measure the 
severity of glaucomatous damage of the visual field. 
Hence, some similarity between the results of the two 
sets was expected. The number of defects on the pattern 
deviation plots was assessed because this map has 
already been set according to each machine’s normative 
database. Nevertheless, the correlation between defects 
was not found in the current study. One might attribute 
this discrepancy to the ability of the FDT to detect VF 
deficit prior to SAP. Several studies suggested that in the 
early stages of glaucoma, Matrix-FDT detected the 
locations of selective loss of retinal ganglion cells in the 
magnocellular pathway more extensively in comparison 
to the defects of VF loss detected by SAP [17, 18]. Our 
results cannot support this theory. In the current study, 
27% of the fields, which were normal with FDT had 
glaucomatous VF defect on SAP. 
Our results are not in agreement with findings of Artes et 
al. that say there is no systematic difference between 
FDT and SAP with regard to PD [19]. However, our results 
are in line with those of Leeprechanon et al. and Patel et 
al. Leeprechanon et al. [11] reported that in the 
glaucoma group, the defect score on the pattern 
deviation plot was higher on FDT than on SAP. However, 
Patel et al. [20] reported that 30% of abnormal SITA 
fields could not be detected by Matrix-FDT. Case 
selection may account for the similarity between FDT and 
SAP in some studies. In a study by Lester et al. [21], in 
which normal or ocular hypertension participants were 
included, by definition no VF defect should be visible on 
the visual fields. Therefore, whenever no defect is visible 
on the field, the results of the VF testing by different 
instruments should be very similar. One possible 
explanation for the poor correlation between the two 
sets in this study might be inexperience of the 
participants with Matrix-FDT. Our study participants 
were experienced with SITA-SAP, but not with FDT. 
Favorable variability characteristics with small learning 
effects have been reported for first-generation FDT in 
participants with perimetric experience [22]. However, 
test practice sessions might decrease the variability of 
the test results and improve the correlation between the 
two sets. Another limitation of our study is that we did 
not perform conformational visual field testing. High test 
variability was reported for the SAP, which despite a 
reliable visual field could result in different field defect 
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[19, 22]. Our study included participants with mild visual 
field damage on SAP, which enabled us to evaluate the 
agreement of two sets in fairly uniform participants. With 
glaucoma progression, test-retest variability would 
increase, and worse agreement between the two sets 
would be expected. Advantages of FDT are its portability 
and quick procedure, which increases patient acceptance 
[23]. Furthermore, it has a role in the early diagnosis of 
glaucoma. However, our study shows that FDT cannot be 
used interchangeably with SAP in the early stage of 
glaucoma because the correlation between the two sets 
is weak in any parameter of the VF. 
 
 
 
 
CONCLUSIONS 
The correlation between Matrix-FDT and SITA-SAP in 
terms of global indices, GHT, number of defective points, 
and stage determination of the visual field damage is 
weak. Therefore, Matrix-FDT cannot be used 
interchangeably with SITA-SAP in the mild stage of 
glaucoma during follow-up. 
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